BORDEAUX, France–(BUSINESS WIRE)–Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS), a clinical-stage biopharmaceutical company specializing in the development of treatments for brain diseases, today announces its indicative financial calendar for the financial year 2024. Event Date of release* 2023 Annual Results Tuesday, April 2, 2024 Annual General Meeting Tuesday, June 4, 2024 2024 Half-Year Results Monday, September 16, 2024 (*) The press releases will be issued after the
Source link
